Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 69
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05648591 | Safety and Tolerability of Open-Labeled Iloperidone in Adolescents | ||
| NCT01218789 | Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception | ||
| NCT04353401 | WGS Analysis of COVID-19 Positive Patients | ||
| NCT01402076 | A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects | ||
| NCT06296966 | A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye | ||
| NCT03838926 | Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies | ||
| NCT01578057 | Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol | ||
| NCT06836557 | Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis | ||
| NCT03568331 | Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE) | ||
| NCT04819776 | Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder | ||
| NCT03373201 | Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia | ||
| NCT06830044 | Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder | ||
| NCT01919944 | Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P | ||
| NCT04028492 | Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis | ||
| NCT03772340 | Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness | ||
| NCT00548340 | VEC-162 Study in Adult Patients With Primary Insomnia | ||
| NCT02004041 | Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis | ||
| NCT00467441 | VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness | ||
| NCT02413918 | Iloperidone in Mixed States of Bipolar Disorder | ||
| NCT06138613 | Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness | ||
| NCT01637636 | Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin. | ||
| NCT06701396 | Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant | ||
| NCT04474990 | Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis | ||
| NCT00254202 | Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia | ||
| NCT02651714 | Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis | ||
| NCT04140695 | Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2) | ||
| NCT02560103 | An Observational Study to Investigate the Effects of Rapid Transmeridian Travel | ||
| NCT06804603 | A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use | ||
| NCT05572281 | Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers | ||
| NCT06803290 | Food Effect Study of VHX-896 in Healthy Volunteers | ||
| NCT01429116 | Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception | ||
| NCT02621385 | Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects | ||
| NCT04327661 | Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness | ||
| NCT04849559 | Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers | ||
| NCT02130999 | Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™) | ||
| NCT01540500 | Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine | ||
| NCT00291187 | VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia | ||
| NCT05361707 | Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances | ||
| NCT03291041 | A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder | ||
| NCT04326426 | ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection | ||
| NCT01291511 | Relapse Prevention Study in Patients With Schizophrenia | ||
| NCT04969211 | Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers | ||
| NCT06494397 | Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions | ||
| NCT03154697 | Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances | ||
| NCT01428661 | Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder | ||
| NCT01348100 | Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients | ||
| NCT02231008 | Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS | ||
| NCT06961968 | Open-Label Evaluation of Relapse Prevention in Patients With Schizophrenia | ||
| NCT02970968 | Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis | ||
| NCT06323655 | Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects |
